Valbiotis SA
EPA:ALVAL.PA
1.354 (EUR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4.733 | 0.785 | 0.298 | 3.092 | 0.091 | 0.079 | 0.003 | 0.646 | 0.01 |
| Cost of Revenue
| 2.733 | 0.018 | 0.016 | 0.004 | 0.017 | 0.398 | 0.069 | 0.026 | 0.038 |
| Gross Profit
| 2 | 0.767 | 0.282 | 3.088 | 0.074 | -0.319 | -0.066 | 0.62 | -0.028 |
| Gross Profit Ratio
| 0.423 | 0.977 | 0.946 | 0.999 | 0.813 | -4.038 | -22 | 0.96 | -2.8 |
| Reseach & Development Expenses
| 7.089 | 8.362 | 6.182 | 4.536 | 3.202 | 3.826 | 1.653 | 0.788 | 0.705 |
| General & Administrative Expenses
| 2.161 | 1.651 | 1.115 | 1.372 | 1.303 | 1.248 | 0.822 | 0.252 | 0 |
| Selling & Marketing Expenses
| 2.016 | 1.703 | 1.509 | 1.023 | 1.471 | 1.058 | 0.533 | 0.183 | 0 |
| SG&A
| 4.147 | 5.636 | 3.976 | 2.968 | 2.944 | 2.525 | 1.52 | 0.435 | 0.358 |
| Other Expenses
| -0.02 | -0.04 | -0.07 | 0 | -0.002 | 0.005 | 0.002 | -0.005 | 0.136 |
| Operating Expenses
| 11.256 | 14.038 | 10.228 | 7.504 | 6.148 | 4.963 | 2.37 | 1.218 | 0.927 |
| Operating Income
| -9.256 | -14.055 | -10.871 | -5.414 | -6.979 | -4.788 | -2.401 | -0.572 | -0.955 |
| Operating Income Ratio
| -1.956 | -17.904 | -36.48 | -1.751 | -76.692 | -60.608 | -800.333 | -0.885 | -95.5 |
| Total Other Income Expenses Net
| -0.14 | -0.149 | 0.44 | 0.328 | 0.255 | -0.179 | -0.042 | -0.021 | -0.011 |
| Income Before Tax
| -9.396 | -14.204 | -10.431 | -5.086 | -6.724 | -4.967 | -2.443 | -0.593 | -0.966 |
| Income Before Tax Ratio
| -1.985 | -18.094 | -35.003 | -1.645 | -73.89 | -62.873 | -814.333 | -0.918 | -96.6 |
| Income Tax Expense
| -2.028 | -1.892 | -1.75 | -1.257 | -1.22 | -1.183 | -0.474 | 0.021 | -0.227 |
| Net Income
| -7.368 | -12.312 | -8.681 | -3.829 | -5.504 | -4.967 | -2.443 | -0.593 | -0.739 |
| Net Income Ratio
| -1.557 | -15.684 | -29.131 | -1.238 | -60.484 | -62.873 | -814.333 | -0.918 | -73.9 |
| EPS
| -0.59 | -1.22 | -0.95 | -0.51 | -1.17 | -1.32 | -0.92 | -0.17 | -60.73 |
| EPS Diluted
| -0.59 | -1.22 | -0.95 | -0.51 | -1.17 | -1.32 | -0.92 | -0.17 | -60.73 |
| EBITDA
| -8.567 | -13.253 | -9.93 | -4.412 | -6.057 | -4.531 | -2.332 | -0.547 | -0.917 |
| EBITDA Ratio
| -1.81 | -16.883 | -33.322 | -1.427 | -66.56 | -57.354 | -777.333 | -0.847 | -91.7 |